*February 2025*
The EGFR Resisters Research Summit is an annual event focusing on the advancement of EGFRm treatment paradigms through meaningful collaboration between physician scientist investigators and patients. This special newsletter includes a summit recap and covers its agenda, including the Awardees and their research projects:
Dr. Catherine Meador, Detecting Small Cell Transformation in Patients with Advanced EGFR-mutant Lung Adenocarcinoma through Epigenomic cfDNA Profiling
Dr. Jessica Stuart, Genomic Landscape of MTAP Deletions and Association with EGFR Alterationsin Patients with Advanced Non–small Cell Lung Cancer
Dr. Bobak Parang, Inhibiting SRPK2 Eradicates EGFR-mutant Drug-tolerant Persister Cells
